Speciality Medicines Ltd Share Price History
BSE : 30 Mar, 2026
125.91.9 (1.5%)
Prev Close
124.0
Open Price
124.0
Bid Price (QTY)
-
Offer Price (QTY)
-
Volume
1423000
Today's High / Low
129.5 / 124.0
52 WK High / Low
129.5 / 124.0
Market Price of Speciality Medicines Ltd
1M
1Y
3Y
5Y
Monitoring Speciality Medicines Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
History Market Price
| Date | Price | Open | High | Low |
|---|
Returns Comparison
1W
1M
3M
6M
1Y
3Y
5Y
10Y
Growth Parameters
| Parameter |  2022 |
|---|---|
| Sales (Cr.) | 40 |
| Sales YoY Gr. | - |
| Adj EPS | 70.45 |
| YoY Gr. | - |
| Net Profit (Cr.) | 1 |
| BVPS | 92.02 |
Key Financial Parameters
| Parameter | 2022 |
|---|---|
| Return on Capital Emp. % | 69.55 |
| Op. Profit Mgn % | 5.64 |
| Net Profit Mgn % | 3.66 |
| Debt to Equity % | 0.61 |
Latest Shareholding
Promoters Holdings Over Time
About Speciality Medicines Ltd
- Speciality Medicines Limited was originally incorporated as 'Speciality Medicines Private Limited' as a Private Limited Company, dated February 05, 2021, issued by the Registrar of Companies, Central Registration Centre.
- Later on, the status was converted to Public Limited and the name of the Company was changed to 'Speciality Medicines Limited' and a fresh Certificate of Incorporation dated June 25, 2024 was issued to the Company by Registrar of Companies. The Promoters, Parth B Goyani and Goyani Sumit Babubhai are associated with the Company and have a combined experience of more than 13 years in the pharmaceutical industry.
- The Company is engaged in marketing & distribution of finished formulations of Specialty pharmaceuticals - high-cost oral or injectable medications used to treat complex chronic conditions in Domestic as well as International Market.
Popular Search
FAQs for null Share Price History
What are the key events that typically impact Speciality Medicines Ltd's share price history?
Key events that impact Speciality Medicines Ltd’s share price history include quarterly earnings releases, product launches, leadership changes, economic policies, and geopolitical developments.
How do stock splits affect Speciality Medicines Ltd's share price history?
Stock splits reduce the nominal price of Speciality Medicines Ltd's shares by increasing the number of outstanding shares, which typically makes the stock more accessible to a broader range of investors. Although the total market value of the company remains unchanged after the split, the split can affect investor perception and liquidity, potentially influencing the share price in the longer term.
How do dividends impact the share price history of Speciality Medicines Ltd?
Dividends can influence Speciality Medicines Ltd's share price history by typically causing a temporary dip on the ex-dividend date, as the stock price often adjusts to reflect the dividend payout. Over time, the impact of dividends on the share price may be offset by the company's overall financial performance and market conditions.
How do corporate announcements affect Speciality Medicines Ltd’s share price history?
Corporate announcements such as mergers, acquisitions, or strategic shifts can lead to significant price changes. Any optimistic development news on Speciality Medicines Ltd generally boosts the company’s share price, whereas negative news can lead to a decline in share price.
How can I use technical analysis to understand Speciality Medicines Ltd’s share price history?
To understand Speciality Medicines Ltd’s share price history using technical analysis, examine charts for patterns such as trends, support, and resistance levels, and apply indicators like moving averages or Relative Strength Index (RSI) to gauge potential future movements. Analyze historical data to identify recurring trends and signals that might suggest how the share price could behave under similar conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
